Reply to comment on "Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease"

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
² Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
³ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, Chi Mei Medical Center, Chia Li Campus, Tainan, Taiwan.
⁴ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: wcchiang@ntu.edu.tw.

Free article

Comment

Ping-Min Chen et al. J Formos Med Assoc. 2015 Jan.

Free article

. 2015 Jan;114(1):95-6.

doi: 10.1016/j.jfma.2014.05.003. Epub 2014 Jun 18.

¹ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
² Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
³ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, Chi Mei Medical Center, Chia Li Campus, Tainan, Taiwan.
⁴ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: wcchiang@ntu.edu.tw.

No abstract available

Comment on

Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease.
Chen PM, Lai TS, Chen PY, Lai CF, Wu V, Chiang WC, Chen YM, Wu KD, Tsai TJ. Chen PM, et al. J Formos Med Assoc. 2014 Apr;113(4):219-26. doi: 10.1016/j.jfma.2014.01.002. Epub 2014 Feb 7. J Formos Med Assoc. 2014. PMID: 24512756
Renoprotective effect of pentoxifylline in advanced chronic kidney disease.
Kao CC, Wu MS. Kao CC, et al. J Formos Med Assoc. 2015 Jan;114(1):94. doi: 10.1016/j.jfma.2014.05.005. Epub 2014 Jun 26. J Formos Med Assoc. 2015. PMID: 24974130 No abstract available.